Tough PTAB Fight Ahead For Breakthrough Gene-Editing Tech

Law360, New York (January 12, 2016, 9:24 PM EST) -- The Patent Trial and Appeal Board decided Monday to begin a proceeding to determine who was the first to invent the breakthrough gene-editing technology known as CRISPR, setting the stage for a winner-take-all showdown between major universities in a fairly obscure patent arena, with billions of dollars in licensing revenue at stake.

Two teams of scientists, one at the University of California, Berkeley, and one at the Massachusetts Institute of Technology and the Broad Institute, each claim to have invented technology to make it easy to edit genes, which has been described as the "holy grail" of molecular biology, capable of...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Patents